https://doi.org/10.4081/hmr.v3i3.569

Radiotherapy in the rituximab era: still a place?

Vol. 3 No. 3: 7th Meeting New Insights in Hematology Venice, Italy, 26-29 April 2009
Published: June 12, 2009
Abstract Views: 251
PDF: 136
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M Pfreundschuh
support@pagepress.org
The RICOVER60 trial has shown that 6 cycles of CHOP-14 with 8 applications of rituximab (6xR-CHOP-14) was superior to 8xR-CHOP-14, 6xCHOP-14 and 8xCHOP-14 in elderly patients with CD20-positive aggressive lymphoma. In that trial 117/306 (36%) of the patients in the 6xRCHOP- 14 arm were assigned to receive additional radiotherapy (Rx) to bulky disease (Pfreundschuh et al., Lancet Oncol 2008). To study the relevance of additional Rx to bulky disease we subsequently initiated a prospective study in which no Rx was planned after 6 x R-CHOP-14.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Pfreundschuh, M. (2009). Radiotherapy in the rituximab era: still a place?. Hematology Meeting Reports (formerly Haematologica Reports), 3(3). https://doi.org/10.4081/hmr.v3i3.569
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).